Relative Efficacy and Safety of Tofacitinib, Baricitinib, Upadacitinib, and Filgotinib in Comparison to Adalimumab in Patients with Active Rheumatoid Arthritis
Z Rheumatol. 2020 DOI: 10.1007/s00393-020-00750-1
View and download slide summaries of the latest original articles focusing on therapies in immune-mediated inflammatory diseases including rheumatology, dermatology, and gastroenterology. All materials produced by the team are subsequently reviewed and approved by individual Steering Committee members.
Z Rheumatol. 2020 DOI: 10.1007/s00393-020-00750-1
Ann Rheum Dis. 2020 10.1136/annrheumdis-2019-216566
Intern Med. 2020;59(6):817-821
Ther Adv Musculoskelet Dis. 2020;12:1759720X19899296
Sci Transl Med 2020;12(530):pii: eaay4447
Ann Rheum Dis. 2020 Jan 22. pii: annrheumdis-2019-216655.
Rheumatol Ther. 2020 DOI: 10.1007/s40744-019-00192-5
Pharmacodynamics. 2020
Clin Transl Sci . 2020 Mar;13(2):325-336. doi: 10.1111/cts.12713. Epub 2019 Nov 29.
Clin Exp Rheumatol . Sep-Oct 2020;38(5):848-857. Epub 2019 Dec 19.